These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11922953)

  • 41. Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis.
    Domanski TL; Halpert JR
    Curr Drug Metab; 2001 Jun; 2(2):117-37. PubMed ID: 11469721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative structure-activity relationships (QSARs) within substrates of human cytochromes P450 involved in drug metabolism.
    Lewis DF; Modi S; Dickins M
    Drug Metabol Drug Interact; 2001; 18(3-4):221-42. PubMed ID: 11791886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined three-dimensional quantitative structure-activity relationship analysis of cytochrome P450 2B6 substrates and protein homology modeling.
    Wang Q; Halpert JR
    Drug Metab Dispos; 2002 Jan; 30(1):86-95. PubMed ID: 11744616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.
    Williams PA; Cosme J; Vinkovic DM; Ward A; Angove HC; Day PJ; Vonrhein C; Tickle IJ; Jhoti H
    Science; 2004 Jul; 305(5684):683-6. PubMed ID: 15256616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Computer modeling the cytochrome P450 three-dimensional structure: problems and prospects].
    Ivanov AS; Skvortsov VS; Sechenykh AA; Dubanov AV; Lisitsa AV
    Biomed Khim; 2003; 49(3):221-37. PubMed ID: 14564732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular modeling of mammalian cytochromes P450: application to study enzyme function.
    Szklarz GD; Graham SE; Paulsen MD
    Vitam Horm; 2000; 58():53-87. PubMed ID: 10668395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of drug metabolism: the case of cytochrome P450 2D6.
    Vermeulen NP
    Curr Top Med Chem; 2003; 3(11):1227-39. PubMed ID: 12769702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modelling human cytochromes P450 for evaluating drug metabolism: an update.
    Lewis DF
    Drug Metabol Drug Interact; 2000; 16(4):307-24. PubMed ID: 11201309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membrane topology of the mammalian P450 cytochromes.
    Black SD
    FASEB J; 1992 Jan; 6(2):680-5. PubMed ID: 1537456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of CYP2C9 with diverse drugs and its implications for metabolic mechanism.
    Wang JF; Yan JY; Wei DQ; Chou KC
    Med Chem; 2009 May; 5(3):263-70. PubMed ID: 19442216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational identification and binding analysis of orphan human cytochrome P450 4X1 enzyme with substrates.
    Kumar S
    BMC Res Notes; 2015 Jan; 8():9. PubMed ID: 25595103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.
    Shoombuatong W; Prathipati P; Prachayasittikul V; Schaduangrat N; Malik AA; Pratiwi R; Wanwimolruk S; Wikberg JES; Gleeson MP; Spjuth O; Nantasenamat C
    Curr Drug Metab; 2017 Jul; 18(6):540-555. PubMed ID: 28322159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of 3-dimensional homology modeling of cytochrome P450 2B1 for interpretation of site-directed mutagenesis results.
    Szklarz GD; Ornstein RL; Halpert JR
    J Biomol Struct Dyn; 1994 Aug; 12(1):061-78. PubMed ID: 7848559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QM/MM modelling of drug-metabolizing enzymes.
    Lonsdale R; Mulholland AJ
    Curr Top Med Chem; 2014; 14(11):1339-47. PubMed ID: 24805066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystallization of cytochromes P450 and substrate-enzyme interactions.
    Li H; Poulos TL
    Curr Top Med Chem; 2004; 4(16):1789-802. PubMed ID: 15579108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.